@article {1535,
	title = {Expanded screening for HIV in the United States--an analysis of cost-effectiveness.},
	journal = {The New England journal of medicine},
	volume = {352},
	year = {2005},
	month = {2005 Feb 10},
	pages = {586-95},
	abstract = {Although the Centers for Disease Control and Prevention (CDC) recommend routine HIV counseling, testing, and referral (HIVCTR) in settings with at least a 1 percent prevalence of HIV, roughly 280,000 Americans are unaware of their human immunodeficiency virus (HIV) infection. The effect of expanded screening for HIV is unknown in the era of effective antiretroviral therapy.},
	keywords = {Anti-Retroviral Agents, Antiretroviral Therapy, Highly Active, Computer Simulation, Cost-Benefit Analysis, Disease Progression, Enzyme-Linked Immunosorbent Assay, Health Care Costs, HIV Antibodies, HIV Infections, Humans, Mass Screening, Monte Carlo Method, Quality-Adjusted Life Years, Risk Factors, United States},
	issn = {1533-4406},
	doi = {10.1111/j.1524-4733.2010.00763.x},
	author = {Paltiel, A David and Weinstein, Milton C and Kimmel, April D and Seage, George R and Losina, Elena and Zhang, Hong and Freedberg, Kenneth A and Walensky, Rochelle P}
}
